HanusP.Metrizamide: A review with emphasis on drug interactions. Am. J Hosp Pharm1980; 37:510–513.
2.
BakerRAHilkmanBJMcLennanJESequelae of metrizamide myelography in 200 examinations. AJR1978; 130:499–502.
3.
BertoniJMSchwartzmanRJVan HornGAsterixis and encephalopathy following metrizamide myelography: Investigations into possible mechanisms and review of the literature. Ann Neurol1981; 9:366–370.
4.
CarellaAFedericoFDi CuonzoFVinjanELambertiP.Adverse effects of metrizamide and iopamidol in myelography; Neuroradiology1982; 22:247–249.
5.
ChehraziBVirapongseA.Transient encephalopathy and asterixis following metrizamide myelography. J Neurosurg1981;55:826–829.
6.
DrayerBPRosenbaumAEHigmanHBCerebrospinal fluid imaging using serial metrizamide cisternography. Neuroradiology1977; 13:7–17.
7.
GelmersHJAdverse side effects of metrizamide in myelography. Neuroradiology1979; 18:119–23.
8.
GelmersHJAcute psycho-organic reactions after cervical myelography using metrizamide. Clin Neurol Neurosurg1981; 83:57–61.
9.
GrepeA.Cisternography with metrizamide of the posterior fossa, following lateral C1-C2 puncture. Acta Radiol Suppl1977; 355:257–268.
10.
HaugeO.FalkenbergH.Neuropsychologic reactions and other side effects after metrizamide myelography. AJR1982; 139:357–60.
11.
KillebrewKWhaleyRAHaywardJNScatliffJHComplications of metrizamide myelography. Arch Neurol1983; 40:78–80.
12.
OkadaKNishimatsuTWadaH.KomatsuS.Transient disturbance of central nervous system after metrizamide cervical myelography. Neuroradiology1982; 22:56.
13.
RobertsonGHEllisGBrismarJCisternography with metrizamide and hypocycloidal tomography. Acta Radiol Suppl1977: 355:314–322.
14.
RubinBHorowitzGKatzRIAsterixis following metrizamide myelography. Arch Neurol1980; 37:522.
SchmidtROMental disorders after myelography with metrizamide and other water-soluble contrast media. Neuroradiology1980; 19:153–157.
17.
SmithMSLaguneJFConfusion, dysphasia and asterixis following metrizamide myelography. Can J Neurol Sci1980; 7:309–11.
18.
SortlandO.Cervical myelography with metrizamide using lumbar injection. Acta Radiol Suppl1977;355:141–153.
19.
SortlandONornesHDjupeslandG.Cisternography with metrizamide in cerebello-pontine angle tumors. Acta Radiol Suppl1977; 355:345–356.
20.
VincentFM, Asterixis after metrizamide myelography, JAMA1980; 244:2727.
21.
VincentFMZimmermanJEMetrizamide encephalopathy. Ann Neurol1980; 7:494.
22.
ElianMFenwickP.Metrizamide and the EEG: Three case reports and a review. J Neurol1985;232:341–345.
23.
GonsetteR.Biological tolerance of the central nervous system to metrizamide. Acta Radiol Stockh1973;335:25–44.
24.
BertoniJMSteinCGCompetitive inhibition of brain hexokinase by metrizamide. Neurology1982;32:320–323.
25.
LeeBCPGomezDCPohsDGPaveseAMSubacute reactions to intrathecal amipaque (metrizamide), conray and dimer-x: A structural and ultra-structural study. Neuroradiology1981; 20:229–233.
26.
CooneyGAEpsteinGMEEG frequency analysis in metrizamide radiography. Neurology1984; 34:1102–1105.
27.
CrumrinePKDrayerBPRosenbaumAEElectroencephalographic changes in pediatric patients following metrizamide cisternography. Child's Brain1983; 10:177–184.
28.
KaadaB.Transient EEG abnormalities following lumbar myelography with metrizamide. Acta Radiol Suppl1973; 335:380–386.
29.
LundervoldA.SortlandO.EEG disturbances following myelography, cisternography and ventriculography with metrizamide. Acta Radiol Suppl1977; 355:379–389.
30.
NakagakiHKatoYNumagughiY.The effects of metrizamide on the EEG. Neuroradiology1981; 22:53.
31.
RopperAHChiappaKHYoungRRThe effect of metrizamide on the electroencephalogram: A prospective study in 61 patients. Ann Neurol1979; 6:222–226.
BergvallUBrismarTLying-TunellUValdimarssonE.Confusion, myoclonus and speech arrest: Epileptic manifestations after metrizamide myelography. Acta Neurol Scand1981;63:315–322.
34.
GraingerRGKendallBEWylieIGLumbar myelography with metrizamide — a new non-ionic contrast medium. Br J Radiol1976; 49:996–1003.
35.
MoschiniLManaraOBonaldiGCassinariVQuiliciNBelloniG.Iopamidol and metrizamide in cervical myelography: Side effects, EEG and CSF changes. Am J Neuroradiol1983; 4:848–850.
36.
NielsenH.Epilpetic seizures following cervical myelography. Neuroradiology1975; 10:59–60.
37.
RussellDAnkeIMNyberg-HansenRComplex partial status epilepticus following myelography with metrizamide. Ann Neurol1980; 8:325–327.
38.
ShiozawaZSassakiHOzakiYNakanishiTHuangY.Epilepsia partialis continua following metrizamide cisternography. Ann Neurol1981; 10:400–1.
PeterssonHFitzCRHarwood-NashCFArmstrongEChuangSHAdverse reactions to myelography with metrizamide in infants, children and adolescents: General and CNS effects. Acta Radiol Diagn1982; 23:323–329.
RobertsonWDLapointeJSNugentRARobinsonRGDalyLFPositioning of patients after metrizamide lumbar myelography. AJR1980; 134:947–948.
43.
BuchmanASKlawansHLRussellEJMetrizamide and its neurologic complications. Clin Neuropharmacol1987; 10:1–25.
44.
NauHEElectroencephalography (EEG) after introduction of water soluble contrast media into cerebrospinal fluid (CSF). Acta Neurochirurgica1981;57:75–82.
45.
AmundsenPWeberHHoelL.Excretion of metrizamide (Amipaque) in humans following lumbar subarachnoid injection. Acta Radiol Diagn1979; 20:401–409.
46.
SykesRHDWasenaarWClarkP.Incidence of adverse effects following metrizamide myelography in non-ambulatory and ambulatory patients. Radiology1981; 138:625–627.
47.
AhlgrenP.Early and late side effects of water-soluble contrast media for myelography and cisternography: A short review. Invest Radiol1980; 15:264–266.
48.
GonsetteRE, Cervical myelography with a new resorbable contrast medium: Amipaque. Acta Neurol Belg1976; 76:283–285.
49.
NickelARSalemJJClinical experience in North America with metrizamide. Acta Radiol (Suppl)1977;355:409–416.
50.
EkholmSEReeceKColemanJRKidoDKFischerHWMetrizamide — a potential in vivo inhibitor of glucose metabolism. Radiology1983; 147:119–121.
